Liu X, Luo J, Zhang L, Yang F, et al. SIB-IMRT combined with apatinib for unresectable hepatocellular carcinoma in patients with poor response to transarterial chemoembolization. Clin Res Hepatol Gastroenterol 2022;46:101897.
PMID: 35240318